248 related articles for article (PubMed ID: 4669430)
41. [The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
Karimov RK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):612-9. PubMed ID: 4574524
[No Abstract] [Full Text] [Related]
42. [Treatment of depression in general practice. A controlled trial of flupenthixol (Fluanxol)].
Frolund F
Ugeskr Laeger; 1973 Jul; 135(29):1507-12. PubMed ID: 4598195
[No Abstract] [Full Text] [Related]
43. [Performance in attention tests in chronic schizophrenics treated with Mepiprazol (author's transl)].
Gonçalves N; Fieguth G
Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):167-77. PubMed ID: 4603734
[No Abstract] [Full Text] [Related]
44. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
45. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
Molcan J; Kukucová H; Koníková M
Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
[No Abstract] [Full Text] [Related]
46. Conditions in adolescents who were borderline psychotics as children. Three cases illustrating diagnostic and therapeutic problems.
Aarkrog T
Acta Psychiatr Scand; 1973; 49(4):377-85. PubMed ID: 4746006
[No Abstract] [Full Text] [Related]
47. Clinical experience with fluspirilene in psychoses.
Svestka J; Náhunek K; Hádlík J; Rodová A
Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825
[No Abstract] [Full Text] [Related]
48. The effect of octoclothepine on sensorimotor coordination of fine movements in chronic schizophrenics.
Remr J
Act Nerv Super (Praha); 1972; 14(2):90-1. PubMed ID: 5040177
[No Abstract] [Full Text] [Related]
49. Antipsychotic properties of loxapine succinate.
Gershon S; Hekimian LJ; Burdock EI; Kim SS
Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
[No Abstract] [Full Text] [Related]
50. [What should the general practitioner know about the treatment of chronic schizophrenia with long-acting neuroleptics?].
Beier R; Friemert K; Vehreschild T
Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1206-7. PubMed ID: 4791840
[No Abstract] [Full Text] [Related]
51. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
[No Abstract] [Full Text] [Related]
52. Parkinsonism with intramuscular ziprasidone.
Bilal L; Tsai C; Gasper JJ; Ndlela JC
Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
[No Abstract] [Full Text] [Related]
53. Piperacetazine in chronic mental patients: clinical observations and new urine color test.
Forrest FM; Forrest IS
Curr Ther Res Clin Exp; 1972 Nov; 14(11):689-95. PubMed ID: 4629106
[No Abstract] [Full Text] [Related]
54. Evaluation of butaperazine in chronic schizophrenia.
Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
[No Abstract] [Full Text] [Related]
55. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
[No Abstract] [Full Text] [Related]
56. Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals.
Vinar O; Hamouz V; Bastecký J
Act Nerv Super (Praha); 1968 Oct; 10(3):315-7. PubMed ID: 4883240
[No Abstract] [Full Text] [Related]
57. [Evaluation of flupenthixol (emergil)].
Bourgeois M
Ann Med Psychol (Paris); 1971 Mar; 1(3):434-43. PubMed ID: 5558678
[No Abstract] [Full Text] [Related]
58. [Report on the clinical testing of the delayed-action form of the neuroleptic agent moperone hydrochloride in 20 chronic psychotic patients].
Lydecken K
Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(1):75-82. PubMed ID: 323966
[TBL] [Abstract][Full Text] [Related]
59. EEG changes in the treatment with octoclothepine in very high doses.
Misurec J; Náhunek K; Svestka J; Rodová A
Act Nerv Super (Praha); 1974; 16(4):244-5. PubMed ID: 4450997
[No Abstract] [Full Text] [Related]
60. Letter: Flupenthixol decanoate and some aggressive states.
O'Flanagan PM
Br Med J; 1974 Jul; 3(5925):258. PubMed ID: 4843702
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
